Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nexium Prescribers Should Be “Embarrassed,” CMS’ Scully Tells AMA

Executive Summary

There is no medical justification for prescribers to choose AstraZeneca's Nexium (esomeprazole) over Prilosec (omeprazole), Centers for Medicare & Medicaid Services Administrator Thomas Scully declared during the American Medical Association advocacy conference March 5 in Washington, D.C

You may also be interested in...



“Lifestyle” Drug Coverage Will Be Federal Policy Issue Under Medicare Rx

The debate over coverage of "lifestyle" drugs is likely to intensify as a federal policy issue once the Medicare prescription drug benefit takes effect in 2006

“Lifestyle” Drug Coverage Will Be Federal Policy Issue Under Medicare Rx

The debate over coverage of "lifestyle" drugs is likely to intensify as a federal policy issue once the Medicare prescription drug benefit takes effect in 2006

AstraZeneca Sets Two NMEs Per Year As Metric Of R&D Success

AstraZeneca is setting a goal of launching two new molecular entities each year, Exec VP-Global Drug Development Martin Nicklasson, PhD, said Feb. 10 at a drug development summit sponsored by R&D Directions in Phoenix

Related Content

UsernamePublicRestriction

Register

PS041403

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel